Literature DB >> 11254226

Acute medical problems in the Himalayas outside the setting of altitude sickness.

B Basnyat1, T A Cumbo, R Edelman.   

Abstract

Well-recognized medical threats at high altitude (>2,500 m) include acute mountain sickness (AMS), high altitude pulmonary edema (HAPE), and high altitude cerebral edema (HACE). Thousands of travelers in the Himalayas are exposed annually to these often life-threatening syndromes. Their recognition and treatment has advanced considerably in recent years. In the Himalayas, we frequently see acute medical problems outside the setting of AMS and the two types of altitude edemas. Many of these other conditions are also hypoxia related and sometimes may mimic the classic high altitude illnesses of AMS, HAPE, and HACE. Although the vast majority of these medical problems are neurological, pulmonary and other organ system dysfunction also occur. These "non-high altitude sickness" disease entities in persons who sojourn to remote mountainous environments are reviewed in this paper to enhance their recognition, diagnosis, and treatment.

Entities:  

Mesh:

Year:  2000        PMID: 11254226     DOI: 10.1089/15270290050144163

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  4 in total

1.  A rare localization of cerebral venous sinus thrombosis. Case report.

Authors:  B Carangelo; L Lavalle; G Tiezzi; D Branco; L Lippa; E Mileo; G Costantino; A Mariottini; G Muscas; A Maturo
Journal:  G Chir       Date:  2015 Mar-Apr

Review 2.  Cerebral venous thrombosis: Update on clinical manifestations, diagnosis and management.

Authors:  Didier Leys; Charlotte Cordonnier
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.714

3.  Reversible diencephalic dysfunction as presentation of deep cerebral venous thrombosis due to hyperhomocysteinemia and protein S deficiency: Documentation of a case.

Authors:  Kaukab Maqbool Hassan; Dheeraj Kumar
Journal:  J Neurosci Rural Pract       Date:  2013-04

4.  AltitudeOmics: Decreased reaction time after high altitude cognitive testing is a sensitive metric of hypoxic impairment.

Authors:  Emma B Roach; Joseph Bleiberg; Corinna E Lathan; Lawrence Wolpert; Jack W Tsao; Robert C Roach
Journal:  Neuroreport       Date:  2014-08-06       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.